Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Inoviq Ltd ( (AU:IIQ) ) has provided an update.
Inoviq Ltd has announced a Share Purchase Plan (SPP) allowing eligible shareholders in Australia and New Zealand to purchase up to A$30,000 worth of shares without incurring additional transaction costs. This initiative aims to strengthen the company’s capital base by offering shares that will rank equally with existing ones, providing shareholders with the same rights and entitlements. The offer is not available to investors in the United States, and the company advises shareholders to rely on their own knowledge and seek advice if necessary before participating.
The most recent analyst rating on (AU:IIQ) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Inoviq Ltd stock, see the AU:IIQ Stock Forecast page.
More about Inoviq Ltd
Inoviq Ltd operates in the biotechnology industry, focusing on the development and commercialization of diagnostic and therapeutic products. The company is listed on the Australian Securities Exchange under the ticker IIQ.
Average Trading Volume: 109,638
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$41.3M
For a thorough assessment of IIQ stock, go to TipRanks’ Stock Analysis page.